Ovarian Cancer Trial, Not Yet Recruiting NCT05956093 Sponsor: University Health Network, Toronto Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Not Yet Recruiting

NCT05956093
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older.
  • People who have been diagnosed with a specific type of ovarian cancer called high-grade serous ovarian cancer (HGSOC) through a tissue or cell sample, or who are strongly suspected to have this cancer based on symptoms, physical examination, tumour markers, and scan results.
  • People whose cancer is at an advanced stage (stage III or IV) and who are being considered for surgery either before or after chemotherapy.
  • People who have had a contrast-enhanced CT scan of the abdomen and pelvis within 6 weeks before a PET scan, prior to joining the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to give informed consent to participate.
  • People for whom a PET scan is not considered safe according to the trial site's guidelines — this includes, but is not limited to, people who are pregnant or who are unable to lie still during the scan.
  • People whose ovarian cancer has been identified as a different, specific subtype — including mucinous, low-grade serous, low-grade endometrioid, or low-malignant potential tumours.
  • People who have an advanced gynaecological cancer that did not originate in the ovaries.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-946-4501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 September 2025
Est. completion
25 April 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

FAPI positivity; Quantitative parameters

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov